Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

16.15

-3.69 (-18.60%)

At close: May 8, 2026, 4:00 PM EDT

16.19

+0.04 (0.25%)

After-hours: May 8, 2026, 7:57 PM EDT

Caris Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	907.29	812.03	412.26	306.13	258.49
Revenue Growth (YoY)	100.51%	96.97%	34.67%	18.43%	-
Cost of Revenue	283.84	272.87	233.48	216.82	178.46
Gross Profit	623.45	539.17	178.78	89.31	80.02
Selling, General & Admin	405.28	392.47	321.99	291.98	294.51
Research & Development	109.83	101.58	113.92	116.88	101.27
Total Operating Expenses	515.11	494.06	435.9	408.86	395.78
Operating Income	108.35	45.11	-257.12	-319.55	-315.76
Interest Income	22.83	16.5	7.12	11.26	0.95
Interest Expense	-56.88	-56.85	-50.03	-31.61	-26.68
Other Non-Operating Income (Expense)	-40.45	-72.85	18.14	-1.51	20.66
Total Non-Operating Income (Expense)	-74.5	-113.2	-24.77	-21.86	-5.07
Pretax Income	33.85	-68.09	-281.89	-341.42	-320.83
Provision for Income Taxes	0.13	-	-	-	-
Net Income	33.47	-68.09	-378.26	-462.53	-320.83
Net Income Attributable to Preferred Dividends	-	-	96.37	121.11	-
Net Income to Common	33.47	-68.09	-378.26	-462.53	-320.83
Shares Outstanding (Basic)	228	167	35	35	0
Shares Outstanding (Diluted)	235	167	35	35	0
Shares Change (YoY)	560.35%	371.04%	1.59%	104626.10%	-
EPS (Basic)	-7.59	-3.22	-10.66	-13.24	-12.00
EPS (Diluted)	-7.61	-3.22	-10.66	-13.24	-12.00
Shares Outstanding	282.65	282.53	35.63	36.27	35.65
Free Cash Flow	123.46	66.9	-253.64	-298.42	-327.96
Free Cash Flow Growth	84.55%	-	-	-	-
Free Cash Flow Per Share	0.52	0.40	-7.15	-8.54	-9829.27
Gross Margin	68.72%	66.40%	43.37%	29.17%	30.96%
Operating Margin	11.94%	5.56%	-62.37%	-104.38%	-122.16%
Profit Margin	3.75%	-8.38%	-68.38%	-111.53%	-124.12%
FCF Margin	13.61%	8.24%	-61.52%	-97.48%	-126.88%
EBITDA	128.98	67.73	-208.21	-270.55	-267.5
EBITDA Margin	14.22%	8.34%	-50.50%	-88.38%	-103.49%
EBIT	108.35	45.11	-257.12	-319.55	-315.76
EBIT Margin	11.94%	5.56%	-62.37%	-104.38%	-122.16%
Effective Tax Rate	0.40%	0.00%	0.00%	0.00%	0.00%

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q